Greg Litwak Email

Director, Quality Assurance . Momenta Pharmaceuticals

Current Roles

Employees:
83
Revenue:
$75M
About
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. We are also utilizing our ability to sequence, or analyze the molecular structure of, sugars to create technology-enabled generic versions of complex sugar-based products. Our most advanced product candidate, M-Enoxaparin, is designed to be a technology-enabled generic version of Lovenox®, a widely prescribed low molecular weight heparin, or LMWH. Our novel product candidates include M118, a LMWH for the treatment of acute coronary syndromes that has been designed to possess specific biological attributes as well as a technology that has been designed to use specific sugar sequences to improve the non-invasive delivery of drugs such as therapeutic proteins.
Momenta Pharmaceuticals Address
301 Binney St
Cambridge, MA
United States
Momenta Pharmaceuticals Email
Momenta Pharmaceuticals Phone Numbers
617-491-9700

Past Companies

Pharmaceutical Advisors and Greg's Quality ConsultingGMP Quality Consultant
Curadel, LLCDirector Of QA
The Janssen Pharmaceutical Companies of Johnson & JohnsonDirector, Quality Assurance

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.